The divergence between long-term institutional buyers and exiting quant funds may reflect a fundamental re-rating opportunity. Traders should monitor upcoming clinical data readouts or regulatory decisions, which could resolve uncertainty and trigger broader institutional alignment.
BMRN drugs
BMRN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 2 $59.71entry
- T+1 · 9mo ago −2.03%α −1.11% · $58.50
- T+5 · 8mo ago +1.57%α +2.78% · $60.65
- T+20 · 8mo ago −8.56%α −0.62% · $54.60
- T+60 · 6mo ago −11.44%α −20.77% · $52.88
How similar events traded
Executive Summary
In Q4 2025, three major institutions, including sovereign wealth fund Norges Bank and passive giants Fidelity and Morgan Stanley, collectively added $598.3M in new positions in BioMarin, while two quant funds, RenTech and Two Sigma, trimmed holdings by $28.2M. The mixed signal suggests分歧 in institutional conviction, with long-term investors accumulating while quantitative strategies reduced exposure.
Key Financial Metrics
Institutional Positions
Net institutional flow: $570.1M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Norges Bank | NEW | +0% | $447.6M | $447.6M |
| Fidelity | DOUBLED | +367.7% | $109.2M | $87.9M |
| Morgan Stanley | ADD | +67.7% | $137.6M | $62.9M |
▼ Sellers (2)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| RenTech | TRIM | -30% | $102.6M | -$23.8M |
| Two Sigma | TRIM | -55.7% | $8.5M | -$4.4M |
Key Facts
- Norges Bank initiated a new $447.6M position in BMRN, the largest single buyer in the cluster.
- Fidelity doubled down with a $87.9M increase, Morgan Stanley added $62.9M.
- RenTech trimmed $23.8M (30% of position), Two Sigma cut $4.4M (55.7%).
- Total institutional net buying: $570.1M (buyers minus sellers).
- Activity dominated by passive/sovereign buyers versus quant sellers.
Financial Impact
3 institutions accumulated $598.3M in new positions while 2 reduced holdings by $28.2M, resulting in net institutional inflow of $570.1M.
Risk Factors
- Quant funds may have risk-off or model-driven exits unrelated to fundamentals.
- Limited insider or activist activity to confirm bullish thesis.
- Sovereign and passive buyers may hold regardless of near-term catalysts, reducing price sensitivity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-BMRN-2025-Q4 |
Track record
16 reports on BMRN
2 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +8.91% at T+60 after the Apr 27, 2026 report. 3 of 5 went positive at some point.
Filters
- Nov 4, 202612d ago SC 13G/A Neutral 3/10 Entry $56.12 to $56.70 ▲ +1.03% −2.26% vs SPY
- Nov 2, 202614d ago 8-K Bearish 6/10 Entry $55.66 to $57.13 ▼ −2.64% −3.23% vs SPY
- Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $57.49 to $56.12 ▼ −2.38% +2.34% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $56.00 to $57.13 ▲ +2.02% +2.73% vs SPY
- Oct 6, 20265w ago 8-K Bearish 6/10 Entry $55.20 to $55.14 ▲ +0.11% −0.87% vs SPY
- Sep 15, 20268w ago 8-K Neutral 4/10 Entry $64.45 to $63.94 ▼ −0.79% −1.61% vs SPY
- Sep 14, 20269w ago 8-K Neutral 2/10 Entry $66.41 to $64.06 ▼ −3.54% −3.65% vs SPY
- Sep 1, 202610w ago 8-K Neutral 3/10 Entry $64.84 to $64.41 ▼ −0.66% −0.74% vs SPY
- Sep 1, 202610w ago Press Release Neutral 4/10 Entry $64.84 to $64.41 ▼ −0.66% −0.74% vs SPY
- Aug 31, 202611w ago 8-K Bullish 6/10 Entry $65.23 to $64.63 ▼ −0.92% −0.78% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers